- Home
- RPTX vs SER Comparison
RPTX vs SER Comparison
Compare RPTX & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- SER
- Stock Information
- Founded
- RPTX 2016
- SER 2017
- Country
- RPTX Canada
- SER United States
- Employees
- RPTX N/A
- SER N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- RPTX Health Care
- SER Health Care
- Exchange
- RPTX Nasdaq
- SER Nasdaq
- Market Cap
- RPTX 38.3M
- SER 53.5M
- IPO Year
- RPTX 2020
- SER 2018
- Fundamental
- Price
- RPTX $1.36
- SER $5.75
- Analyst Decision
- RPTX Strong Buy
- SER Strong Buy
- Analyst Count
- RPTX 3
- SER 1
- Target Price
- RPTX $4.50
- SER $11.00
- AVG Volume (30 Days)
- RPTX 508.5K
- SER 12.0K
- Earning Date
- RPTX 05-20-2025
- SER 05-24-2025
- Dividend Yield
- RPTX N/A
- SER N/A
- EPS Growth
- RPTX N/A
- SER N/A
- EPS
- RPTX N/A
- SER N/A
- Revenue
- RPTX $53,477,000.00
- SER $56,000.00
- Revenue This Year
- RPTX N/A
- SER N/A
- Revenue Next Year
- RPTX $7.14
- SER N/A
- P/E Ratio
- RPTX N/A
- SER N/A
- Revenue Growth
- RPTX 4.58
- SER N/A
- 52 Week Low
- RPTX $0.89
- SER $3.81
- 52 Week High
- RPTX $4.29
- SER $14.57
- Technical
- Relative Strength Index (RSI)
- RPTX 59.23
- SER 54.32
- Support Level
- RPTX $1.25
- SER $5.64
- Resistance Level
- RPTX $1.48
- SER $6.61
- Average True Range (ATR)
- RPTX 0.11
- SER 0.48
- MACD
- RPTX 0.01
- SER -0.02
- Stochastic Oscillator
- RPTX 57.14
- SER 53.51
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.